Evidence-based recommendations for cancer nausea and vomiting

Arash Naeim, Sydney E Dy, Karl A. Lorenz, Homayoon Sanati, Anne Walling, Steven M. Asch

Research output: Contribution to journalArticle

Abstract

The experience of patients living with cancer and being treated with chemotherapy often includes the symptoms of nausea and vomiting. To provide a framework for high-quality management of these symptoms, we developed a set of key targeted evidence-based standards through an iterative process of targeted systematic review, development, and refinement of topic areas and standards and consensus ratings by a multidisciplinary expert panel as part of the RAND Cancer Quality-Assessing Symptoms Side Effects and Indicators of Supportive Treatment Project. For nausea and vomiting, key clinical standards included screening at the initial outpatient and inpatient visit, prophylaxis for acute and delayed emesis in patients receiving moderate to highly emetic chemotherapy, and follow-up after treatment for nausea and vomiting symptoms. In addition, patients with cancer and small bowel obstruction were examined as a special subset of patients who present with nausea and vomiting. The standards presented here for preventing and managing nausea and vomiting in cancer care should be incorporated into care pathways and should become the expectation rather than the exception.

Original languageEnglish (US)
Pages (from-to)3903-3910
Number of pages8
JournalJournal of Clinical Oncology
Volume26
Issue number23
DOIs
StatePublished - 2008

Fingerprint

Nausea
Vomiting
Neoplasms
Emetics
Drug Therapy
Inpatients
Outpatients
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Naeim, A., Dy, S. E., Lorenz, K. A., Sanati, H., Walling, A., & Asch, S. M. (2008). Evidence-based recommendations for cancer nausea and vomiting. Journal of Clinical Oncology, 26(23), 3903-3910. https://doi.org/10.1200/JCO.2007.15.9533

Evidence-based recommendations for cancer nausea and vomiting. / Naeim, Arash; Dy, Sydney E; Lorenz, Karl A.; Sanati, Homayoon; Walling, Anne; Asch, Steven M.

In: Journal of Clinical Oncology, Vol. 26, No. 23, 2008, p. 3903-3910.

Research output: Contribution to journalArticle

Naeim, A, Dy, SE, Lorenz, KA, Sanati, H, Walling, A & Asch, SM 2008, 'Evidence-based recommendations for cancer nausea and vomiting', Journal of Clinical Oncology, vol. 26, no. 23, pp. 3903-3910. https://doi.org/10.1200/JCO.2007.15.9533
Naeim, Arash ; Dy, Sydney E ; Lorenz, Karl A. ; Sanati, Homayoon ; Walling, Anne ; Asch, Steven M. / Evidence-based recommendations for cancer nausea and vomiting. In: Journal of Clinical Oncology. 2008 ; Vol. 26, No. 23. pp. 3903-3910.
@article{3fe108630bb14a7fb65df5a0c9816ad8,
title = "Evidence-based recommendations for cancer nausea and vomiting",
abstract = "The experience of patients living with cancer and being treated with chemotherapy often includes the symptoms of nausea and vomiting. To provide a framework for high-quality management of these symptoms, we developed a set of key targeted evidence-based standards through an iterative process of targeted systematic review, development, and refinement of topic areas and standards and consensus ratings by a multidisciplinary expert panel as part of the RAND Cancer Quality-Assessing Symptoms Side Effects and Indicators of Supportive Treatment Project. For nausea and vomiting, key clinical standards included screening at the initial outpatient and inpatient visit, prophylaxis for acute and delayed emesis in patients receiving moderate to highly emetic chemotherapy, and follow-up after treatment for nausea and vomiting symptoms. In addition, patients with cancer and small bowel obstruction were examined as a special subset of patients who present with nausea and vomiting. The standards presented here for preventing and managing nausea and vomiting in cancer care should be incorporated into care pathways and should become the expectation rather than the exception.",
author = "Arash Naeim and Dy, {Sydney E} and Lorenz, {Karl A.} and Homayoon Sanati and Anne Walling and Asch, {Steven M.}",
year = "2008",
doi = "10.1200/JCO.2007.15.9533",
language = "English (US)",
volume = "26",
pages = "3903--3910",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "23",

}

TY - JOUR

T1 - Evidence-based recommendations for cancer nausea and vomiting

AU - Naeim, Arash

AU - Dy, Sydney E

AU - Lorenz, Karl A.

AU - Sanati, Homayoon

AU - Walling, Anne

AU - Asch, Steven M.

PY - 2008

Y1 - 2008

N2 - The experience of patients living with cancer and being treated with chemotherapy often includes the symptoms of nausea and vomiting. To provide a framework for high-quality management of these symptoms, we developed a set of key targeted evidence-based standards through an iterative process of targeted systematic review, development, and refinement of topic areas and standards and consensus ratings by a multidisciplinary expert panel as part of the RAND Cancer Quality-Assessing Symptoms Side Effects and Indicators of Supportive Treatment Project. For nausea and vomiting, key clinical standards included screening at the initial outpatient and inpatient visit, prophylaxis for acute and delayed emesis in patients receiving moderate to highly emetic chemotherapy, and follow-up after treatment for nausea and vomiting symptoms. In addition, patients with cancer and small bowel obstruction were examined as a special subset of patients who present with nausea and vomiting. The standards presented here for preventing and managing nausea and vomiting in cancer care should be incorporated into care pathways and should become the expectation rather than the exception.

AB - The experience of patients living with cancer and being treated with chemotherapy often includes the symptoms of nausea and vomiting. To provide a framework for high-quality management of these symptoms, we developed a set of key targeted evidence-based standards through an iterative process of targeted systematic review, development, and refinement of topic areas and standards and consensus ratings by a multidisciplinary expert panel as part of the RAND Cancer Quality-Assessing Symptoms Side Effects and Indicators of Supportive Treatment Project. For nausea and vomiting, key clinical standards included screening at the initial outpatient and inpatient visit, prophylaxis for acute and delayed emesis in patients receiving moderate to highly emetic chemotherapy, and follow-up after treatment for nausea and vomiting symptoms. In addition, patients with cancer and small bowel obstruction were examined as a special subset of patients who present with nausea and vomiting. The standards presented here for preventing and managing nausea and vomiting in cancer care should be incorporated into care pathways and should become the expectation rather than the exception.

UR - http://www.scopus.com/inward/record.url?scp=51349126924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51349126924&partnerID=8YFLogxK

U2 - 10.1200/JCO.2007.15.9533

DO - 10.1200/JCO.2007.15.9533

M3 - Article

VL - 26

SP - 3903

EP - 3910

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 23

ER -